Showing results (61-70 of 93) with videos related to
Sort By:
Pageof 10
JCI Insight|August 4, 2017
microRNA-143/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancerSharon Wang, Jeff C Liu, YoungJun Ju, et al.Medical Oncology (Northwood, London, England)|March 27, 2025
Vitamin D3 and its active form calcitriol suppress erythroleukemia through upregulation of CHAC1 and downregulation of NOTCH1Jiankun Hong, Zhongyou Yang, Jian Gao, et al.Journal of Inflammation Research|May 16, 2023
FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia ProgressionJifen Hu, Jian Gao, Chunlin Wang, et al.Bioorganic & Medicinal Chemistry|November 26, 2018
Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancerXiao Xiao, Mei Xu, Chao Yang, et al.Medical Oncology (Northwood, London, England)|December 31, 2022
FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genesDanmei Sheng, Beiling Chen, Chunlin Wang, et al.Cell Death Discovery|November 6, 2022
UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progressionAnling Hu, Jian Gao, Krishnapriya M Varier, et al.Cellular Signalling|February 1, 2022
FLI1 regulates inflammation-associated genes to accelerate leukemogenesisBeiling Chen, Danmei Sheng, Chunlin Wang, et al.Frontiers in Pharmacology|July 15, 2024
B4 suppresses lymphoma progression by inhibiting fibroblast growth factor binding protein 1 through intrinsic apoptosisKrishnapriya M Varier, Gou Dan, Xiaolong Li, et al.BMC Cancer|April 4, 2023
Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signalingJian Gao, Jifen Hu, Fang Yu, et al.BMC Cancer|August 4, 2019
Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activityNing Wang, Yanhua Fan, Chun-Mao Yuan, et al.Pageof 10